Importantly, the p53-deficient skin carcinomas shared GE patterns with metastatic samples arising in a Kras/p53R172H and a Kras/Lkb1L/L LAd GEMM [10], [11], confirming their aggressive molecular properties (highlighted in pink, Fig. 1B). The gene discussed is KRAS; the disease is skin carcinoma.